Literature DB >> 22946283

Estrogen therapy in Turner syndrome: does the type, dose and mode of delivery matter?

Nelly Mauras1, Lournaris Torres-Santiago, Martha Taboada, Richard Santen.   

Abstract

The best type, dose and route of estrogen replacement in hypogonadal females has not been fully elucidated and is the subject of this brief review. When feminizing girls with different forms of hypogonadism micronized 17betaE2 should be considered the first choice as it is the most physiological and can be accurately measured in plasma. Most studies of the metabolic effects of the different routes have also used different types of estrogen making comparisons difficult. However, when using the same estradiol compound, 17betaE2 transdermal results in E2, E1 and bioestrogen concentrations closer to normal as compared to oral and achieves greater suppression of LH/FSH but similar IGF-I and lipid concentrations. Whether this translates into better body composition and metabolic outcomes in girls with hypogonadism is being actively investigated and data will soon be available.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22946283

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  2 in total

1.  Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Charmian A Quigley; Xiaohai Wan; Sipi Garg; Karen Kowal; Gordon B Cutler; Judith L Ross
Journal:  J Clin Endocrinol Metab       Date:  2014-04-24       Impact factor: 5.958

2.  Concurrent insulinoma with mosaic Turner syndrome: A case report.

Authors:  Shaoyun Wang; Lijuan Yang; Jie Li; Yiming Mu
Journal:  Exp Ther Med       Date:  2015-01-05       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.